Figure 2From: Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis ICER (In EURO per DALY averted) depending on the initial cost of GA-I screening (direct cost of GA-I screening, in EURO per newborn over a 20 year horizon). Back to article page